MiR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression

Claire Corcoran, Sweta Rani, Lorraine O'Driscoll

Research output: Contribution to journalArticlepeer-review

153 Citations (Scopus)

Fingerprint

Dive into the research topics of 'MiR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression'. Together they form a unique fingerprint.

Medicine & Life Sciences